According to a recent press release, Artios Pharma has begun dosing patients in a global Phase 2 clinical trial evaluating its investigational DNA polymerase theta (Polθ) inhibitor, ART6043, in combination…
Artios Pharma has achieved a significant milestone in cancer treatment development with the U.S. Food and Drug Administration's granting of Fast Track designation to ART6043, a potentially first-in-class DNA polymerase…
The FDA has granted IDEAYA Biosciences fast track status for IDE161 as a treatment for HR+, Her2- breast cancer. The therapy is a selective inhibitor of ADP ribose glycohydrolase…
In a joint statement, biopharmaceutical companies AstraZeneca and Merck & Co., Inc. ("Merck") shared that LYNPARZA (olaparib) achieved a superiority boundary in the Phase 3 OlympiA clinical trial. During…
Twins Iris and Clarisa Valdez recently shared their story of courage and hope and thanked the City of Hope care team for its guidance and support. But most importantly…
A recent release from Yale University highlights research from Dr. Kutluk Oktay, a fertility expert, on how BRCA-mutated breast cancer may affect fertility following chemotherapy treatments. His findings suggest that women…
Meredith Resnick's breast cancer risk is 42%. This risk is made up of her higher breast density (denser breasts are associated with increased risk), Ashkenazi Jewish heritage, a family history…
.jpg)
OncLive recently published the views of several speakers at its State of the Science Summit on breast cancer. Stephanie LaBomascus, MD gave a presentation that highlighted triple negative breast…
An article originally published by CBS New York recently emphasized the importance of regular mammograms for detecting breast cancer, even in families with no history of mutated BRCA genes. What…
.jpg)
Stephanie Hosford was recently interviewed by CURE (Cancer Updates Research and Education) about what she now calls her “three crazy days”. The title of her book is “Bald, Fat and…
A new study has found that 80 percent of people who have an identifiable genetic risk for cancer due to a mutated BRCA1/2 gene don’t know they're at risk. The…
According to a story from Oncology Times, a recent study indicates that the PARP inhibitor drug talazoparib could be an effective treatment option for patients with advanced, HER-2 negative, BRCA…
According to a story from medicinenet.com, a recent study found that women on Medicare are not getting genetic tests for BRCA mutations that could lead to ovarian cancer and breast…
According to the Dover Post, there are a few crucial questions to ask your doctor upon being diagnosed with breast cancer. By asking these crucial questions, patients will be…
According to a story from rdmag.com, researchers from the University of Toronto have discovered a critical mechanism that helps facilitate the normal DNA repair process. This mechanism could have implications…
According to a story from Jewish Community Voice, the BRCA Founder Outreach Study, which is a national, cancer-focused research study, is offering free screenings for people of Ashkenazi Jewish descent.…
According to a story from The Guardian, doctors are celebrating the effectiveness of an all new, experimental immunotherapy that was able to totally eliminate a case of metastatic breast cancer…
According to a story from cancer.nautil.us, some cancer researchers are beginning to look at the animal kingdom in order to find new answers for finding what it takes to beat…
According to a story from Ovarian Cancer News, a recent study has allowed scientists to determine why some people appear to be resistant to poly ADP ribose polymerase (PARP) inhibitors.…
The Young family from Oregon, U.S. have used genetic screening to test their embryos for a variation of the BRCA gene that significantly increases the risk of breast cancer, reports…
Do you have to be tested for an inherited gene mutation if you have already had cancer? Can a woman get a genetic mutation from her father? If you have…
According to a story from mrknewsroom.com, the pharmaceutical companies Merck and AstraZeneca recently announced that the marketing application for the investigational drug olaparib (brand name Lynparza) was recently certified for…
According to a story from sunmag.net, 23andMe, the genetics testing company widely known for its ancestral analysis measures, is now offering a genetics test to measure your risk of BRCA1…
According to a story from CBS DFW, doctors have begun to test the use of fluorescent dyes in order to detect hidden cancer tumors. So far, the dyes appear to…
Author Emma Hannigan passed away March 3rd 2018. Hannigan led a life of strength and dignity, persevering through her cancer diagnosis. Her husband, Cian, left a touching tribute to his…
© Copyright 2024 Patient Worthy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
